Since hyperglycemia resulting from hyperthyroidism is considered reversible after treatment of thyrotoxicosis [33,34], the change in plasma glucose level might also partially account for the decreased expression of hepassocin. The gene discussed is FGL1; the disease is thyrotoxicosis.